Hantz Financial Services’s ARK Genomic Revolution ETF ARKG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-150
Closed -$4K 1060
2024
Q1
$4K Hold
150
﹤0.01% 958
2023
Q4
$5K Buy
+150
New +$4.08K ﹤0.01% 904

Other funds holding ARKG

Hantz Financial Services's ARKG Position: Q2 2024 in Review

Hantz Financial Services sold out of ARK Genomic Revolution ETF (ARKG) in Q2 2024, closing a stake of 150 shares — an estimated $4K sold.

Hantz Financial Services first reported a position in ARKG in Q4 2023 and held it in 2 quarters. The position peaked at $5K in Q4 2023. 261 funds tracked by Wall St. Rank hold ARKG as of Q2 2024.

  • Hantz Financial Services reported no remaining ARK Genomic Revolution ETF position as of Q2 2024 after selling out during the quarter.
  • Hantz Financial Services sold 150 ARK Genomic Revolution ETF shares in Q2 2024, an estimated $4K.
  • Hantz Financial Services first reported a position in ARK Genomic Revolution ETF in Q4 2023 and held it in 2 quarters.
  • Hantz Financial Services's ARK Genomic Revolution ETF position peaked at $5K in Q4 2023.
  • 261 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2024.

Based on Hantz Financial Services's 13F filing for Q2 2024, filed 30 Jul 2024.